ASMB vs ZBH · rev $21.6M vs P/E 23, rev $4.26B
Assembly Biosciences Inc (ASMB) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Assembly Biosciences Inc (ASMB) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported ASMB revenue for 2026-06-30 was $21.6M. Net income was -$12.9M. ASMB currently screens at market cap $143.0M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
ASMB currently screens at market cap $143.0M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the ASMB and ZBH stock pages for the full models.
Not investment advice.